677 related articles for article (PubMed ID: 17267580)
1. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
[TBL] [Abstract][Full Text] [Related]
2. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
Kosowski AR; Liljequist S
J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
[TBL] [Abstract][Full Text] [Related]
3. Spreading depression: imaging and blockade in the rat neocortical brain slice.
Anderson TR; Andrew RD
J Neurophysiol; 2002 Nov; 88(5):2713-25. PubMed ID: 12424306
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
[TBL] [Abstract][Full Text] [Related]
5. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro.
Fischer G; Mutel V; Trube G; Malherbe P; Kew JN; Mohacsi E; Heitz MP; Kemp JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1285-92. PubMed ID: 9400004
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-D-aspartate receptor antagonists for migraine: a potential therapeutic approach.
Ye R; Kong X; Han J; Zhao G
Med Hypotheses; 2009 May; 72(5):603-5. PubMed ID: 19168292
[TBL] [Abstract][Full Text] [Related]
7. CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents.
Menniti FS; Pagnozzi MJ; Butler P; Chenard BL; Jaw-Tsai SS; Frost White W
Neuropharmacology; 2000 Apr; 39(7):1147-55. PubMed ID: 10760358
[TBL] [Abstract][Full Text] [Related]
8. Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.
Blanchet PJ; Konitsiotis S; Whittemore ER; Zhou ZL; Woodward RM; Chase TN
J Pharmacol Exp Ther; 1999 Sep; 290(3):1034-40. PubMed ID: 10454475
[TBL] [Abstract][Full Text] [Related]
9. Tonic facilitation of glutamate release by glycine binding sites on presynaptic NR2B-containing NMDA autoreceptors in the rat visual cortex.
Li YH; Han TZ; Meng K
Neurosci Lett; 2008 Feb; 432(3):212-6. PubMed ID: 18248890
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of ifenprodil against spreading depression in the mouse entorhinal cortex.
Faria LC; Mody I
J Neurophysiol; 2004 Oct; 92(4):2610-4. PubMed ID: 15201313
[TBL] [Abstract][Full Text] [Related]
11. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
[TBL] [Abstract][Full Text] [Related]
12. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain.
Nellgård B; Wieloch T
Acta Physiol Scand; 1992 Dec; 146(4):497-503. PubMed ID: 1283483
[TBL] [Abstract][Full Text] [Related]
13. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
Aracava Y; Pereira EF; Maelicke A; Albuquerque EX
J Pharmacol Exp Ther; 2005 Mar; 312(3):1195-205. PubMed ID: 15522999
[TBL] [Abstract][Full Text] [Related]
14. Late phase of long-term potentiation induced by co-application of N-methyl-d-aspartic acid and the antagonist of NR2B-containing N-methyl-d-aspartic acid receptors in rat hippocampus.
Oh-Nishi A; Saji M; Satoh SZ; Ogata M; Suzuki N
Neuroscience; 2009 Mar; 159(1):127-35. PubMed ID: 19010396
[TBL] [Abstract][Full Text] [Related]
15. Glutamate-based therapeutic approaches: NR2B receptor antagonists.
Gogas KR
Curr Opin Pharmacol; 2006 Feb; 6(1):68-74. PubMed ID: 16376149
[TBL] [Abstract][Full Text] [Related]
16. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
Gilling KE; Jatzke C; Hechenberger M; Parsons CG
Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
[TBL] [Abstract][Full Text] [Related]
17. Induction of cAMP response element modulator (CREM) and inducible cAMP early repressor (ICER) expression in rat brain by uncompetitive N-methyl-D-aspartate receptor antagonists.
Storvik M; Lindén AM; Kontkanen O; Lakso M; Castrén E; Wong G
J Pharmacol Exp Ther; 2000 Jul; 294(1):52-60. PubMed ID: 10871295
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
Whittemore ER; Ilyin VI; Woodward RM
J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex.
Obrenovitch TP; Zilkha E
Br J Pharmacol; 1996 Mar; 117(5):931-7. PubMed ID: 8851513
[TBL] [Abstract][Full Text] [Related]
20. Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat.
Nash JE; Hill MP; Brotchie JM
Exp Neurol; 1999 Jan; 155(1):42-8. PubMed ID: 9918703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]